Efficacy of intravenous nalbuphine on spinal morphine prevention pruritus after Caesarian delivery

Abstract

The purpose of this research was to study the Efficacy of intravenous nalbuphine on spinal morphine prevention pruritus after Caesarian delivery. The sample consisted of 120 elective Caesarian patients; receive 0.2 mg spinal morphine, 3 mg intravenous nalbuphine prevention pruritus after Caesarian delivery. Collection data were retrospective Caesarian section chart review from October to December 2023, Use the pruritus assessment form.  Reliability of the tools was tested using Cronbach’s alpha coefficient yielding values of 0.89 respectively. Data were analyzed using descriptive, frequency statistics, percentage, mean, standard deviation and Pearson’ s Product Moment Correlation.

The results of this study revealed as follows : The majority of the sample group was 26-30 years old (45.83%), 53.33% weighed 70-80 kilograms. 72.5% the surgery period was 30-45 minutes, 42.5% received Nalbuphine after 5-10 minutes of spinal morphine and 40.83% followed by 11-15 minutes. 78.33% pruritus after Caesarian delivery to epidural morphine > 12 hours and 15.83% followed by < 6 hours. 98.33% pruritus on the face and body. the severity of itching was level 1(53.33%) and 46.67% there was no pruritus at all and 98.33% no medication was required to relieve itching. There were no complications from the use of Nalbuphine(98.33%). Nausea and vomiting after surgery were reported in 1.67 percent. Correlation analysis Weight and duration of intravenous nalbuphine administration after spinal morphine were found to have a statistically significant positive relationship with itch severity at a high level (r = 0.910 and 0.801).

Conclusion: weight and duration of intravenous nalbuphine administration after spinal morphine are related to the severity of pruritus.